Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Li Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8969-7427; OpenAlex author ID A5100336122. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 9

  1. The glycolytic enzyme PGK1 phosphorylates MORC2 to Confer radioresistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-025-08177-9↗
  2. Hexokinase 2 nonmetabolic function-mediated phosphorylation of IκBα enhances pancreatic ductal adenocarcinoma progression. Co-author DOI 10.1111/cas.16204↗
  3. Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreat… Co-author DOI 10.3389/fgene.2021.817672↗
  4. lncRNA-XLOC_012370 Promotes the Development of Pancreatic Cancer and Inactivates the NF-κB Pathway Through miR-140-5p. Co-author DOI 10.3389/fonc.2020.620550↗
  5. [Expressions of stem cell factor and hypoxia inducible factor 1 alpha in pancreatic cancer cells and related mechanism]. Last author PMID 28712399↗
  6. SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer. Last author DOI 10.18632/oncotarget.5647↗
  7. [Association between pancreatic cancer risk and the interaction of U2AF65 gene polymorphisms and smoking]. Last author PMID 25174478↗
  8. ShRNA silencing glycogen synthase kinase-3 beta inhibits tumor growth and angiogenesis in pancreatic cancer. First author DOI 10.1016/j.canlet.2011.10.033↗
  9. [Expression of hypoxia inducible factor-1α and insulin in pancreatic cancer and their correlation]. Co-author DOI 10.3760/cma.j.issn.0253-3766.2012.05.006↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yingying Tong · 2 shared papers, 2024–2025 · strength 0.43
  2. Jing Wang · 2 shared papers, 2024–2025 · strength 0.43
  3. yaoxian Xiang · 2 shared papers, 2024–2025 · strength 0.43
  4. Dong Yan · 2 shared papers, 2024–2025 · strength 0.43
  5. Lijun Yang · 1 shared paper, 2025 · strength 0.22
  6. Yi Zhang · 1 shared paper, 2021 · strength 0.14
  7. Qiongying Hu · 1 shared paper, 2021 · strength 0.14
  8. Bole Tian · 1 shared paper, 2021 · strength 0.14
  9. Han-Xiao Nie · 1 shared paper, 2020 · strength 0.13
  10. Baishun Wan · 1 shared paper, 2020 · strength 0.13
  11. Ling Zhang · 1 shared paper, 2020 · strength 0.13
  12. Feng Han · 1 shared paper, 2020 · strength 0.13
  13. Jing Tian · 2 shared papers, 2014–2015 · strength 0.09
  14. Rong Zhong · 2 shared papers, 2014–2015 · strength 0.09
  15. Xiaoping Miao · 2 shared papers, 2014–2015 · strength 0.09
  16. Yao Tian · 2 shared papers, 2014–2015 · strength 0.09
  17. Beibei Zhu · 2 shared papers, 2014–2015 · strength 0.09
  18. Yunjian Wang · 1 shared paper, 2017 · strength 0.08
  19. Min Zhang · 1 shared paper, 2017 · strength 0.08
  20. Nanmu Yang · 1 shared paper, 2017 · strength 0.08
  21. Tongling Wang · 2 shared papers, 2012 · strength 0.07
  22. Shanmiao Gou · 2 shared papers, 2012 · strength 0.07
  23. Chunyou Wang · 2 shared papers, 2012 · strength 0.07
  24. Li Zou · 1 shared paper, 2015 · strength 0.04
  25. Wei Zhou · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.